The HALT-PKD trial (14, 15) demonstrated the benefits of strict blood pressure control and the effectiveness of blockade of the renin-angiotensin-aldosterone system in the reduction of progression of early ADPKD. This evidence concerns the gene REN and autosomal dominant polycystic kidney disease.